Massachusetts General Hospital: Bone Diseases, Metabolic trials
The registry lists 12 Bone Diseases, Metabolic studies with Massachusetts General Hospital as lead sponsor. 0 are open to participants now and 8 have results posted.
Phase 2 4Phase 3 5Phase 4 1No phase 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Denosumab to Prevent High-Turnover Bone Loss After Bariatric SurgeryCompletedNCT04087096Phase 4Results posted
- Effects of Denosumab on Bone Mineral Density in Women With Anorexia Nervosa: A Pilot StudyCompletedNCT03292146Phase 3Results posted
- Study of Growth Hormone and Bone in ObesityCompletedNCT01724489Not applicableResults posted
- Testosterone and Alendronate in Hypogonadal MenTerminatedNCT01460654Phase 2Results posted
- IGF-1 and Bone Loss in Women With Anorexia NervosaCompletedNCT01406444Not applicableResults posted
- Fat Mediated Modulation of Reproductive and Endocrine Function in Young AthletesCompletedNCT00946192Phase 3Results posted
- Effect of Growth Hormone on Bone Metabolism in Anorexia NervosaCompletedNCT00283595Phase 2Results posted
- Bone Loss in Women With Anorexia NervosaCompletedNCT00089843Phase 2/3Results posted
- Bone Mass Accrual in Adolescent AthletesWithdrawnNCT00827151Phase 3
- Hormone Dynamics and Bone Mineral Density in Anorexia Nervosa v. Hypothalamic AmenorrheaCompletedNCT00556036
- Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate CancerCompletedNCT00181584Phase 2
- Effects of Parathyroid Hormone in Men With OsteoporosisCompletedNCT00000427Phase 3